These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 19010161)

  • 1. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation.
    Raszeja-Wyszomirska J; Wasilewicz MP; Wunsch E; Szymanik B; Jarosz K; Wójcicki M; Milkiewicz P
    Transplant Proc; 2009 Oct; 41(8):3114-6. PubMed ID: 19857689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.
    Huo TI; Lin HC; Wu JC; Hou MC; Lee FY; Lee PC; Chang FY; Lee SD
    Clin Transplant; 2006; 20(2):188-94. PubMed ID: 16640525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
    Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
    Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
    Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S; Ghani H; Memon S; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.